Citations

Showing 10 of 107930 citations.

Parametric Quantitative Acoustic Analysis of Conversation Produced by Speakers With Dysarthria and Healthy Speakers
Rosen, Kristin M., Kent, Raymond D. , Delaney, Amy L. , Duffy, Joseph R.

Mayo Clinic

Journal of Speech, Language, and Hearing Research | December 30, 2009 | Volume: 49 | Issue: 2 | Pages: 395-411

10.1044/1092-4388(2006/031) | PMID 16671852 Get It

Purpose This study’s main purpose was to (a) identify acoustic signatures of hypokinetic dysarthria (HKD) that are robust to phonetic variation in conversational speech and (b) determine specific characteristics of the variability associated with HKD. Method Twenty healthy control (HC) participants and 20 participants with HKD associated with idiopathic Parkinson’s disease (PD) repeated 3 isolated sentences (controlled phonetic content) and 2 min of conversational speech (phonetic content treated as a random variable). A MATLAB-based program automatically calculated measures of contrastivity: speech–pause ratio, intensity variation, median and maximum formant slope, formant range, change in the upper and lower spectral envelope, and range of the spectral envelope. t tests were used to identify which measures were sensitive to HKD and which measures differed by task. Discriminant analysis was used to identify the combination of measures that best predicted HKD, and this analysis was then used as a general measure of contrastivity (Contrastivity Index). Differential effects of HKD on maximum and typical contrastivity levels were tested with interaction of maximum, minimum, and median observations of individual speakers and with pairwise comparisons of skewness and kurtosis of the contrastivity index distributions. Results Group differences were detected with pairwise comparisons with t tests in 8 of the 9 measures. Percentage pause time and spectral range were identified as the most specific (95%) and accurate (95%) differentiators of HKD and HC conversational speech. Sentence repetition elicited significantly higher levels of contrastivity than conversational speech in both HC and HKD speakers. Maximum and minimum contrastivities were significantly lower in HKD speech, but there was no evidence that HKD affects maximum contrastivity levels more than median contrastivity levels. The HKD speakers' contrastivity distributions were significantly more skewed to lower levels of production. Conclusion HKD can be consistently distinguished from HC speech in both sentence repetition and conversational speech on the basis of intensity variation and spectral range. Although speakers with HKD were effectively able to produce higher contrastivity levels in sentence repetition tasks, they habitually performed closer to the lower end of their production ranges.
High-Sensitivity Cardiac Troponin: Hype, Help, and Reality
Jaffe, Allan S. , Apple, Fred S. , Jaffe, Allan S.

Mayo Clinic

Clinical Chemistry | December 30, 2009 | Volume: 56 | Issue: 3 | Pages: 342-344

10.1373/clinchem.2009.136218 | PMID 20040616 Get It

Sharply Increased Serum Free Light-Chain Concentrations after Treatment for Multiple Myeloma
Murata, Kazunori , Clark, Raynell, Lockington, Karen S., Tostrud, Linda J., Greipp, Philip R., Katzmann, Jerry A.

Mayo Clinic

Clinical Chemistry | December 29, 2009 | Volume: 56 | Issue: 1 | Pages: 16-18

10.1373/clinchem.2009.133041 | PMID 20040623 Get It

Addressing the Global Burden of Surgical Disease: Proceedings from the 2nd Annual Symposium at the American College of Surgeons
Perkins, R. Serene, Casey, Kathleen M., McQueen, Kelly, Casey, Kathleen M.

Mayo Clinic

World Journal of Surgery | December 29, 2009 | Volume: 34 | Issue: 3 | Pages: 371-373

10.1007/s00268-009-0338-2 | PMID 20041251 Get It

AbstractIn the past decade, interest in surgery as a means to improve public health and engage in international service has increased significantly. International organizations, academic institutions, professional associations, and humanitarian aid organizations recognize that disparate access to surgical care affects global health and they have recently joined forces to address access to surgical care. Current initiatives focus on quantitatively defining surgical disparity, prioritizing a surgical agenda, and developing economically sustainable models for health care assistance, training, and delivery. The Global Burden of Surgical Disease Working Group (GBoSD WG) strives to (1) quantitatively define global disparity in surgical care; (2) assess unmet surgical need; (3) identify priorities; (4) develop sustainable models for improved health care delivery; and (5) advocate for a surgical presence within the global public health agenda. This article formally introduces the GBoSD Working Group and papers presented during the 2009 Symposium at the American College of Surgeons in Chicago.
Love and Fear of Heights: The Pathophysiology and Psychology of Height Imbalance
Salassa, John R., Zapala, David A.

Mayo Clinic

Wilderness & Environmental Medicine | December 28, 2009 | Volume: 20 | Issue: 4 | Pages: 378-382

10.1580/1080-6032-020.004.0378 | PMID 20030449 Get It

Individual psychological responses to heights vary on a continuum from acrophobia to height intolerance, height tolerance, and height enjoyment. This paper reviews the English literature and summarizes the physiologic and psychological factors that generate different responses to heights while standing still in a static or motionless environment. Perceptual cues to height arise from vision. Normal postural sway of 2 cm for peripheral objects within 3 m increases as eye-object distance increases. Postural sway >10 cm can result in a fall. A minimum of 20 minutes of peripheral retinal arc is required to detect motion. Trigonometry dictates that a 20-minute peripheral retinal arch can no longer be achieved in a standing position at an eye-object distance of >20 m. At this distance, visual cues conflict with somatosensory and vestibular inputs, resulting in variable degrees of imbalance. Co-occurring deficits in the visual, vestibular, and somatosensory systems can significantly increase height imbalance. An individual's psychological makeup, influenced by learned and genetic factors, can influence reactions to height imbalance. Enhancing peripheral vision and vestibular, proprioceptive, and haptic functions may improve height imbalance. Psychotherapy may improve the troubling subjective sensations to heights.
Ictal SPECT statistical parametric mapping in temporal lobe epilepsy surgery
Kazemi, Noojan , Stead, S. Matt, Brinkmann, Benjamin H. , Mullan, Brian P., O’Brien, Terence J. , So, E. L., Worrell, Gregory A. , Brinkmann, Benjamin H

Mayo Clinic

Neurology | December 28, 2009 | Volume: 74 | Issue: 1 | Pages: 70-76

10.1212/wnl.0b013e3181c7da20 | PMID 20038775 Get It

Impact of Retail Medicine on Standard Costs in Primary Care: A Semiparametric Analysis
Rohrer, James E. , Angstman, Kurt B. , Bartel, Gregory A.

Mayo Clinic

Population Health Management | December 28, 2009 | Volume: 12 | Issue: 6 | Pages: 333-335

10.1089/pop.2009.0007 | PMID 20038259 Get It

Retail medicine clinics have become widely available. However, few studies have been published that compare retail clinic costs of care to standard medical visits for similar patients. The purpose of this study was to compare standard medical costs during a 6-month period after visiting a retail medical clinic to care received in a conventional medical office setting. Medical records of primary care patients (both adults and children) seen in a large group practice in Minnesota in 2008 were analyzed for this study. Two groups of patients were studied: those who used a retail walk-in clinic (N = 141) and a comparison group who used regular office care for same-day, acute visits (N = 137). Patients treated for 5 common conditions (pink eye, sore throat, viral illness, bronchitis, and cough) were selected. The dependent variables were standard costs using federal rates and the rank of standard costs. Multiple linear regression analysis was used to adjust for differences between groups. Median costs did not differ between sites ($126.30 for usual care and $88.10 for retail, P = 0.139); mean cost ranks were 132.5 for usual care and 115.6 for retail ( P = 0.088). After adjusting for previous visit history, age, and sex, patients who received care in the retail setting had lower standard costs and lower cost rank than patients who received usual care (b = −52.9 [ P = 0.006] and b = −24.5 [ P = 0.021], respectively). After selection of cases with common conditions and adjustment for unequal variances, age, sex, and number of office visits in the previous 6 months, our retail clinic appeared to reduce medical costs for patients during the 6-month period after the index visit. ( Population Health Management 2009;12:333–335)
Equilibrative nucleoside transporter 1 plays an essential role in cardioprotection
Rose, Jennifer B. , Naydenova, Zlatina, Bang, Andrew , Eguchi, Megumi, Sweeney, Gary , Hammond, James R. , Coe, Imogen R. , Choi, Doo‐Sup

Mayo Clinic

American Journal of Physiology-Heart and Circulatory Physiology | December 25, 2009 | Volume: 298 | Issue: 3 | Pages: H771-H777

10.1152/ajpheart.00711.2009 | PMID 20035027 Get It

To better understand the role of equilibrative nucleoside transporters (ENT) in purine nucleoside-dependent physiology of the cardiovascular system, we investigated whether the ENT1-null mouse heart was cardioprotected in response to ischemia (coronary occlusion for 30 min followed by reperfusion for 2 h). We observed that ENT1-null mouse hearts showed significantly less myocardial infarction compared with wild-type littermates. We confirmed that isolated wild-type adult mouse cardiomyocytes express predominantly ENT1, which is primarily responsible for purine nucleoside uptake in these cells. However, ENT1-null cardiomyocytes exhibit severely impaired nucleoside transport and lack ENT1 transcript and protein expression. Adenosine receptor expression profiles and expression levels of ENT2, ENT3, and ENT4 were similar in cardiomyocytes isolated from ENT1-null adult mice compared with cardiomyocytes isolated from wild-type littermates. Moreover, small interfering RNA knockdown of ENT1 in the cardiomyocyte cell line, HL-1, mimics findings in ENT1-null cardiomyocytes. Taken together, our data demonstrate that ENT1 plays an essential role in cardioprotection, most likely due to its effects in modulating purine nucleoside-dependent signaling and that the ENT1-null mouse is a powerful model system for the study of the role of ENTs in the physiology of the cardiomyocyte.
Allogeneic transplantation for therapy-related myelodysplastic syndrome and acute myeloid leukemia
Litzow, Mark R. , Tarima, Sergey , Pérez, Waleska S., Bolwell, Brian J., Cairo, Mitchell S. , Camitta, Bruce M., Luger, Selina M. , Marks, David I. , Pasquini, Marcelo C. , Phillips, Gordon L., Rizzo, J. Douglas , Sierra, Jorge , Tallman, Martin S. , Weisdorf, Daniel J. , Cutler, Corey S. , Lima, Marcos de , DiPersio, John F. , Gale, Robert Peter , Keating, Armand , Lazarus, Hillard M. , Maziarz, Richard Thomas , McCarthy, Philip L. , Weisdorf, Dan

Mayo Clinic

Blood | December 24, 2009 | Volume: 115 | Issue: 9 | Pages: 1850-1857

10.1182/blood-2009-10-249128 | PMID 20032503 Get It

Abstract Therapy-related myelodysplastic syndromes (t-MDSs) and acute myeloid leukemia (t-AML) have a poor prognosis with conventional therapy. Encouraging results are reported after allogeneic transplantation. We analyzed outcomes in 868 persons with t-AML (n = 545) or t-MDS (n = 323) receiving allogeneic transplants from 1990 to 2004. A myeloablative regimen was used for conditioning in 77%. Treatment-related mortality (TRM) and relapse were 41% (95% confidence interval [CI], 38-44) and 27% (24-30) at 1 year and 48% (44-51) and 31% (28-34) at 5 years, respectively. Disease-free (DFS) and overall survival (OS) were 32% (95% CI, 29-36) and 37% (34-41) at 1 year and 21% (18-24) and 22% (19-26) at 5 years, respectively. In multivariate analysis, 4 risk factors had adverse impacts on DFS and OS: (1) age older than 35 years; (2) poor-risk cytogenetics; (3) t-AML not in remission or advanced t-MDS; and (4) donor other than an HLA-identical sibling or a partially or well-matched unrelated donor. Five-year survival for subjects with none, 1, 2, 3, or 4 of these risk factors was 50% (95% CI, 38-61), 26% (20-31), 21% (16-26), 10% (5-15), and 4% (0-16), respectively (P < .001). These data permit a more precise prediction of outcome and identify subjects most likely to benefit from allogeneic transplantation.